Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TAVR Evolution On Display At EuroPCR

This article was originally published in The Gray Sheet

Executive Summary

Data on both new transcatheter aortic valve technologies and established TAVR devices were featured at this year’s EuroPCR meeting in Paris.

You may also be interested in...



People Briefs

Israeli firm Insightec appoints former Mako Surgical co-founder and chair as CEO, ACell taps new president and CEO, and more personnel updates from JenaValve Technology, Zeltiq and Reva Medical.

TAVR Performance Sustained In Long-Term Data

Five-year follow-up data on Edwards’ Sapien and two-year data on Medtronic’s CoreValve presented at the TCT conference in Washington, D.C., show sustained efficacy and safety for transcatheter aortic valves in patients too ill for surgery.

New Products: Direct Flow TAVR Systemn; Phillips TAVR Navigator; AliveCor AFib Detector

Direct Flow has earned a CE Mark for the 23mm version of its transcatheter aortic heart valve system. FDA clears Phillips’ precision planning application for transcatheter valve implants. FDA approves an atrial fibrillation detection indication for AliveCor’s mobile phone-based heart monitor. More new product news.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033032

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel